Edition:
United States

Pfizer Inc (PFE)

PFE on New York Consolidated

44.06USD
21 Sep 2018
Change (% chg)

$0.31 (+0.71%)
Prev Close
$43.75
Open
$43.78
Day's High
$44.19
Day's Low
$43.61
Volume
35,192,233
Avg. Vol
19,944,287
52-wk High
$44.19
52-wk Low
$33.20

Chart for

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.96
Market Cap(Mil.): $258,284.50
Shares Outstanding(Mil.): 5,862.11
Dividend: 0.34
Yield (%): 3.09

Financials

  PFE Industry Sector
P/E (TTM): 20.19 30.48 32.69
EPS (TTM): 2.18 -- --
ROI: 9.65 13.04 12.72
ROE: 20.52 14.99 14.85

Smiths and ICU Medical healthcare merger talks collapse

British engineering firm Smiths Group Plc said on Thursday talks with U.S.-based ICU Medical Inc over a possible 7 billion pound-plus ($9.2 billion) merger of their healthcare businesses had fallen through.

Sep 13 2018

UPDATE 3-Smiths and ICU Medical healthcare merger talks collapse

* Shares of ICU Medical drop 8 pct, Smiths ends down 0.2 pct (Adds ICU shares, analyst comments)

Sep 13 2018

TREASURIES OUTLOOK-Yields rise on strong U.S. manufacturing data, corporate debt supply

NEW YORK, Sept 4 U.S. Treasury yields rose to three week highs on Tuesday after data showed that U.S. manufacturing activity accelerated to a more than 14-year high in August, and on heavy corporate debt supply.

Sep 04 2018

TREASURIES-Yields rise on strong U.S. manufacturing data, corporate debt supply

NEW YORK, Sept 4 U.S. Treasury yields rose to three week highs on Tuesday after data showed that U.S. manufacturing activity accelerated to a more than 14-year high in August, and on heavy corporate debt supply.

Sep 04 2018

TREASURIES-Yields rise as investors prepare for corporate debt supply

NEW YORK, Sept 4 U.S. Treasury yields rose on Tuesday as investors prepared for heavy corporate debt supply and as falling Italian debt yields reduced safety demand for U.S. government debt.

Sep 04 2018

Judge rejects Hospira's bid to void $70 mln biosimilar patent verdict

A federal judge has rejected Pfizer Inc unit Hospira's bid to overturn a jury's verdict finding that it infringed a patent held by Amgen Inc by producing a biosimilar version of its anemia drug Epogen and owed the pharmaceutical company $70 million.

Aug 28 2018

Pfizer rare heart disease drug reduces risk of death by 30 percent in study

NEW YORK Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 percent, boosting the prospects of what could be a billion-dollar-a-year drug.

Aug 27 2018

Pfizer rare heart disease drug reduces risk of death by 30 pct in study

NEW YORK, Aug 27 Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 percent, boosting the prospects of what could be a billion-dollar-a-year drug.

Aug 27 2018

Pfizer loses bid to escape Lipitor antitrust lawsuit

A federal judge has rejected Pfizer Inc's bid to escape an antitrust lawsuit accusing it of conspiring with India's Ranbaxy Laboratories Ltd to delay sales of generic versions of its cholesterol drug Lipitor.

Aug 22 2018

Pfizer, Astellas revise two cancer drug trial protocols to speed up results

Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.

Aug 22 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $142.88 +0.90
Novartis AG (NOVN.S) CHF81.88 -0.06
Merck & Co., Inc. (MRK.N) $71.10 +0.32
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
Abbott Laboratories (ABT.N) $69.05 +0.26
Bayer AG (BAYGn.DE) €76.52 +0.70
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.50 -0.17
AstraZeneca plc (AZN.L) 5,670.00 +98.00

Earnings vs. Estimates